This study aims to assess the effect of radiation treatment on the tumour vasculature and its downstream effects on hypoxia and choline metabolism using a multimodal approach in the murine prostate tumour model CWR22.
Functional parameters derived from Positron Emission Tomography (PET)/Computer Tomography (CT) with (18)F-Fluoromisonidazole ((18)F-FMISO) and (18)F-Fluorocholine ((18)F-FCH) as well as Dynamic Contrast-Enhanced Ultrasound (DCE-US) were employed to determine the relationship between metabolic parameters and microvascular parameters that reflect the tumour microenvironment. Immunohistochemical analysis was employed for validation.
PET/CT and DCE-US were acquired pre- and post-treatment, at day 0 and day 3, respectively. At day 1, radiation treatment was delivered as a single fraction of 10 Gy. Two experimental groups were tested for treatment response with (18)F-FMISO and (18)F-FCH.
The maximum Standardized Uptake Values (SUVmax) and the mean SUV (SUVmean) for the (18)F-FMISO group were decreased after treatment, and the SUVmean of the tumour-to-muscle ratio was correlated to microvessel density (MVD) at day 3. The kurtosis of the amplitude of the contrast uptake A was significantly decreased for the control tumours in the (18)F-FCH group. Furthermore, the eliminating rate constant of the contrast agent from the plasma k el derived from DCE-US was negatively correlated to the SUVmean of tumour-to-muscle ratio, necrosis and MVD.
The present study suggests that the multimodal approach using (18)F-FMISO PET/CT and DCE-US seems reliable in the assessment of both microvasculature and necrosis as validated by histology. Thus, it has valuable diagnostic and prognostic potential for early non-invasive evaluation of radiotherapy.
Journal of translational medicine. 2015 Dec 18*** epublish ***
Natalia Arteaga-Marrero, Cecilie Brekke Rygh, Jose F Mainou-Gomez, Tom C H Adamsen, Nataliya Lutay, Rolf K Reed, Dag R Olsen
Department of Physics and Technology, University of Bergen, P. O. Box 7803, Bergen, 5020, Norway. Department of Biomedicine, University of Bergen, Bergen, Norway. Department of Clinical Medicine, University of Bergen, Bergen, Norway. Department of Radiology, Haukeland University Hospital, Bergen, Norway. Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden. Department of Biomedicine, University of Bergen, Bergen, Norway. Department of Physics and Technology, University of Bergen, P. O. Box 7803, Bergen, 5020, Norway.